Chun Shing Kwok1, S Matthijs Boekholdt2, Marleen A H Lentjes3, Yoon K Loke4, Robert N Luben3, Jessica K Yeong5, Nicholas J Wareham6, Phyo K Myint7, Kay-Tee Khaw3. 1. Epidemiology Group, Division of Applied Health Sciences, School of Medicine & Dentistry, University of Aberdeen, Aberdeen, UK Cardiovascular Institute, University of Manchester, Manchester, UK. 2. Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands. 3. Department of Public Health & Primary Care, University of Cambridge, Cambridge, UK. 4. Department of Public Health & Primary Care, Norwich Medical School, University of East Anglia, Norwich, UK. 5. Lancashire Teaching Hospital NHS Foundation Trust, Preston, UK. 6. Medical Research Council Epidemiology Unit, Cambridge, UK. 7. Epidemiology Group, Division of Applied Health Sciences, School of Medicine & Dentistry, University of Aberdeen, Aberdeen, UK.
Abstract
OBJECTIVE: To examine the association between chocolate intake and the risk of future cardiovascular events. METHODS: We conducted a prospective study using data from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort. Habitual chocolate intake was quantified using the baseline food frequency questionnaire (1993-1997) and cardiovascular end points were ascertained up to March 2008. A systematic review was performed to evaluate chocolate consumption and cardiovascular outcomes. RESULTS: A total of 20,951 men and women were included in EPIC-Norfolk analysis (mean follow-up 11.3±2.8 years, median 11.9 years). The percentage of participants with coronary heart disease (CHD) in the highest and lowest quintile of chocolate consumption was 9.7% and 13.8%, and the respective rates for stroke were 3.1% and 5.4%. The multivariate-adjusted HR for CHD was 0.88 (95% CI 0.77 to 1.01) for those in the top quintile of chocolate consumption (16-99 g/day) versus non-consumers of chocolate intake. The corresponding HR for stroke and cardiovascular disease (cardiovascular disease defined by the sum of CHD and stroke) were 0.77 (95% CI 0.62 to 0.97) and 0.86 (95% CI 0.76 to 0.97). The propensity score matched estimates showed a similar trend. A total of nine studies with 157,809 participants were included in the meta-analysis. Higher compared to lower chocolate consumption was associated with significantly lower CHD risk (five studies; pooled RR 0.71, 95% CI 0.56 to 0.92), stroke (five studies; pooled RR 0.79, 95% CI 0.70 to 0.87), composite cardiovascular adverse outcome (two studies; pooled RR 0.75, 95% CI 0.54 to 1.05), and cardiovascular mortality (three studies; pooled RR 0.55, 95% CI 0.36 to 0.83). CONCLUSIONS: Cumulative evidence suggests that higher chocolate intake is associated with a lower risk of future cardiovascular events, although residual confounding cannot be excluded. There does not appear to be any evidence to say that chocolate should be avoided in those who are concerned about cardiovascular risk. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: To examine the association between chocolate intake and the risk of future cardiovascular events. METHODS: We conducted a prospective study using data from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort. Habitual chocolate intake was quantified using the baseline food frequency questionnaire (1993-1997) and cardiovascular end points were ascertained up to March 2008. A systematic review was performed to evaluate chocolate consumption and cardiovascular outcomes. RESULTS: A total of 20,951 men and women were included in EPIC-Norfolk analysis (mean follow-up 11.3±2.8 years, median 11.9 years). The percentage of participants with coronary heart disease (CHD) in the highest and lowest quintile of chocolate consumption was 9.7% and 13.8%, and the respective rates for stroke were 3.1% and 5.4%. The multivariate-adjusted HR for CHD was 0.88 (95% CI 0.77 to 1.01) for those in the top quintile of chocolate consumption (16-99 g/day) versus non-consumers of chocolate intake. The corresponding HR for stroke and cardiovascular disease (cardiovascular disease defined by the sum of CHD and stroke) were 0.77 (95% CI 0.62 to 0.97) and 0.86 (95% CI 0.76 to 0.97). The propensity score matched estimates showed a similar trend. A total of nine studies with 157,809 participants were included in the meta-analysis. Higher compared to lower chocolate consumption was associated with significantly lower CHD risk (five studies; pooled RR 0.71, 95% CI 0.56 to 0.92), stroke (five studies; pooled RR 0.79, 95% CI 0.70 to 0.87), composite cardiovascular adverse outcome (two studies; pooled RR 0.75, 95% CI 0.54 to 1.05), and cardiovascular mortality (three studies; pooled RR 0.55, 95% CI 0.36 to 0.83). CONCLUSIONS: Cumulative evidence suggests that higher chocolate intake is associated with a lower risk of future cardiovascular events, although residual confounding cannot be excluded. There does not appear to be any evidence to say that chocolate should be avoided in those who are concerned about cardiovascular risk. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Nicholas J Wareham; Rupert W Jakes; Kirsten L Rennie; Jo Mitchell; Susie Hennings; Nicholas E Day Journal: Int J Epidemiol Date: 2002-02 Impact factor: 7.196
Authors: Luc Djoussé; Paul N Hopkins; Kari E North; James S Pankow; Donna K Arnett; R Curtis Ellison Journal: Clin Nutr Date: 2010-09-19 Impact factor: 7.324
Authors: Pamela J Mink; Carolyn G Scrafford; Leila M Barraj; Lisa Harnack; Ching-Ping Hong; Jennifer A Nettleton; David R Jacobs Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Adriana Buitrago-Lopez; Jean Sanderson; Laura Johnson; Samantha Warnakula; Angela Wood; Emanuele Di Angelantonio; Oscar H Franco Journal: BMJ Date: 2011-08-26
Authors: Elizabeth Mostofsky; Martin Berg Johansen; Anne Tjønneland; Harpreet S Chahal; Murray A Mittleman; Kim Overvad Journal: Heart Date: 2017-05-23 Impact factor: 5.994
Authors: Yuk-Lam Ho; Xuan-Mai T Nguyen; Joseph Q Yan; Jason L Vassy; David R Gagnon; J Michael Gaziano; Peter Wf Wilson; Kelly Cho; Luc Djoussé Journal: Am J Clin Nutr Date: 2021-03-01 Impact factor: 8.472
Authors: James A Greenberg; JoAnn E Manson; Marian L Neuhouser; Lesley Tinker; Charles Eaton; Karen C Johnson; James M Shikany Journal: Am J Clin Nutr Date: 2018-07-01 Impact factor: 7.045
Authors: Howard D Sesso; JoAnn E Manson; Aaron K Aragaki; Pamela M Rist; Lisa G Johnson; Georgina Friedenberg; Trisha Copeland; Allison Clar; Samia Mora; M Vinayaga Moorthy; Ara Sarkissian; William R Carrick; Garnet L Anderson Journal: Am J Clin Nutr Date: 2022-06-07 Impact factor: 8.472
Authors: C S Kwok; Y K Loke; A A Welch; R N Luben; M A H Lentjes; S M Boekholdt; R Pfister; M A Mamas; N J Wareham; K-T Khaw; P K Myint Journal: Nutr Metab Cardiovasc Dis Date: 2016-01-28 Impact factor: 4.222